Prospective data collection of off-label use of rituximab in Australian public hospitals.
about
Off-label use of targeted therapies in oncologyRituximab in autoimmune diseasesIt is time to review how unlicensed medicines are usedOutcomes of off-label drug uses in hospitals: a multicentric prospective studyPharmacokinetics and pharmacokinetic-pharmacodynamic relationships of monoclonal antibodies in children.The double misfortune: time to improve off-label immune intervention.
P2860
Prospective data collection of off-label use of rituximab in Australian public hospitals.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Prospective data collection of off-label use of rituximab in Australian public hospitals.
@ast
Prospective data collection of off-label use of rituximab in Australian public hospitals.
@en
type
label
Prospective data collection of off-label use of rituximab in Australian public hospitals.
@ast
Prospective data collection of off-label use of rituximab in Australian public hospitals.
@en
prefLabel
Prospective data collection of off-label use of rituximab in Australian public hospitals.
@ast
Prospective data collection of off-label use of rituximab in Australian public hospitals.
@en
P2860
P356
P1476
Prospective data collection of off-label use of rituximab in Australian public hospitals.
@en
P2093
P2860
P304
P356
10.1111/IMJ.12206
P577
2013-08-01T00:00:00Z